(Q40527438)

English

Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer

scientific article published on August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1016/j.surg.2023.01.008

https://retractionwatch.com/2023/02/14/harvard-surgeon-has-five-papers-pulled-following-internal-investigation/

Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer (English)

1 reference

Europe PubMed Central

21 September 2017

RNA interference

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Mark S Duxbury

1

1 reference

Europe PubMed Central

21 September 2017

Hiromichi Ito

2

1 reference

Europe PubMed Central

21 September 2017

Eric Benoit

3

1 reference

Europe PubMed Central

21 September 2017

Michael J Zinner

4

1 reference

Europe PubMed Central

21 September 2017

Stanley W Ashley

5

1 reference

Europe PubMed Central

21 September 2017

Edward E Whang

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

1 reference

publication date

1 August 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

136

1 reference

Europe PubMed Central

21 September 2017

2

1 reference

Europe PubMed Central

21 September 2017

261-269

1 reference

Europe PubMed Central

21 September 2017

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

2 references

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/SJ.ONC.1207272

30 December 2023

Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Multiple transcription factor profiling by enzyme-linked immunoassay

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Stable suppression of tumorigenicity by virus-mediated RNA interference

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Retrovirus-delivered siRNA

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.SURG.2004.04.029

30 December 2023

Identifiers

10.1016/J.SURG.2004.04.029

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40527438&oldid=2041352441"